Researchers developed a “tumor-on-a-chip” system designed to recreate that environment outside the human body, offering a more realistic way to study the disease and evaluate treatments.
Professor Iksung Kang (School of Electrical Engineering), in collaboration with Professor Na Ji’s research team at UC Berkeley, has developed a technology that accurately corrects image aberrations in microscopes used for live biological imaging.
LAGUNA HILLS, Calif., April 29, 2026 /PRNewswire/ — Prelude Corporation (PreludeDx™), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for the AidaBREAST® test.
HERSHEY, Pa., April 29, 2026 /PRNewswire/ — Chest Wall Innovations, a medical device company focused on advancing the standard of care in chest wall surgery, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its PC Fix Rib Fixation System on April 24, 2026, clearing the path for U.S. commercialization.
An anonymous gift helped Tufts researchers speed up a project to develop new drugs that could prevent and treat Lyme disease
Discover how smell receptors in our noses aren’t randomly arranged but are highly organized, offering new paths toward treating sensory impairment.
Medtronic (NYSE:MDT) announced today that it received CE mark approval for its Stealth AXiS surgical robot platform.
Abbott (NYSE:ABT) announced today that it received FDA clearance and CE mark for its next-generation Ultreon 3.0 software.
Olympus announced today that it received FDA 510(k) clearance for its Powerseal open extended jaw sealer/divider for use in open surgery
An AI model (REDMOD) can pick up the very early subtle tissue changes of pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer, which conventional imaging and the human eye find difficult to detect, finds research published online in the journal Gut.